Zinc Supplementation Versus Placebo for Bronchiolitis Management in Children: A Comparative Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230729058959N1

Enrollment

102

Registered

2023-09-14

Start date

2022-12-15

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis. Acute bronchiolitis

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Age

2 Months to 23 Months

Inclusion criteria

Inclusion criteria: Children with age group 2 - 23 months having Clinical signs & symptoms of acute bronchiolitis

Exclusion criteria

Exclusion criteria: Use of mechanical ventilation in neonates or History of prematurity Recent use of antibiotic Congenital heart and lung disease Down syndrome Respiratory failure signs Immunodeficiency Previous wheezing episodes history Family history of allergies and/or asthma Metabolic or neurological diseases Zinc intake during the previous one month

Design outcomes

Primary

Measure	Time frame
Wheezing. Timepoint: 24, 48, 72, 96 and 120 hours. Method of measurement: questionnaire.	—

Countries

Pakistan

Contacts

Public ContactDr Ali Hamza Arshad

Children hospital and university of child health sciences

Drhamzaarshad92@gmail.com+92 333 4379801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026